- 18.9k views
Critical Care Procedures Done in COVID ICU
Acute respiratory distress syndrome (ARDS), septic shock, thromboembolic disease, hepatic and/or renal dysfunction, central nervous system disease, and worsening of underlying comorbidities are just a few of the serious illnesses that COVID-19 can advance to in both adults and children. In addition, the multisystem inflammatory syndrome in adults (MIS-A), which can cause catastrophic disease, can develop weeks or months following SARS-CoV-2 infection. These Guidelines' initial advice for treating critically unwell people with COVID-19 was largely drawn from knowledge of other causes of sepsis and respiratory failure. 1 However, there is currently a rapidly expanding corpus of research on the management of severely ill COVID-19 patients. In the critical care unit (ICU), treating COVID-19 patients frequently necessitates controlling underlying conditions.
About the Speaker
Dr. Aklesh Tandekar
CRITICAL CARE SPECIALIST MD, EDIC, IDCCM, FIMSA, DA, FCPS, FISCCM
Watch Next
ICU Delirium Management & Prophylaxis
Dr Akhlesh Tandelkarr is Senior Registrar in Tata Memorial Hospital,Mumbai. He was Associate Consultant, P.D Hinduja National Hospital, Mumbai, Assistant Professor in Anesthesia and Critical Care, LTMMC and LTMGH, Sion Mumbai, and as Chief Intensivist, Nanavati Super Speciality hospital. He was certified in Honor in Anatomy,Physiology, Medicine and Surgery,and was also awarded for Appreciation for Approach to patient. Has also received an Award for Service to Humanity by Brihanmumbai Corporation of Greater Mumbai. He has also published a Case report on Anesthesia for cases of complicated Hemophilia with Orthopedic emergency.
Case Discussion on Respiratory Failure and Ventilation
The illness known as respiratory failure occurs when either one or both of the respiratory system's two gas exchange processes—oxygenation and carbon dioxide elimination—fail. It can be categorized as either hypoxemic or hypercapnic in real life. When arterial carbon dioxide tension is normal or low and arterial oxygen tension (PaO2) is less than 60 mm Hg, hypoxemic respiratory failure (type I) is present (PaCO2). The most prevalent type of respiratory failure, which is characterized by the fluid filling or collapse of alveolar units, is connected to almost all acute lung illnesses.
Case Discussion on Management of ECMO
ECMO is a form of life support that uses a machine to oxygenate the blood outside of the body used for patients with severe respiratory or cardiac failure who are not responding to conventional treatment. ECMO can be used in both adult and pediatric patients. Hemodynamic parameters such as heart rate, blood pressure, and oxygen saturation are closely monitored during ECMO management. The goal of ECMO management is to provide temporary support for the patient until their own cardiac or respiratory function can be restored.
ICU Psychosis: A Critical overview
Long stays in ICUs increase the risk of developing ICU psychosis. It is a mental disorder that affects people admitted to intensive care units which typically resolves within a few days to weeks after discharge from the ICU. It is characterized by confusion, disorientation, and delusions. Early recognition and treatment of ICU psychosis can help improve patient outcomes and reduce the risk of long-term complications. Treatment may include reducing the use of sedatives and other medications, providing a calming environment, and using antipsychotic medication.
Case based discussion of Non Invasive Ventilation
Non-invasive ventilation refers to the administration of ventilatory support without using an invasive artificial airway. It has been used as a replacement for invasive ventilation, and its flexibility also allows it to be a valuable complement in patient management. Join us in this interactive discussion with Dr Hazem Lashin Consultant in Critical Care Medicine at NHS, who will be discussing the significant role of Non-Invasive Ventilation and its uses with a deep dive understanding.
Author Post
Impact
+
Talks
+
webinar
+
no.of registrations
One liner about speaker
Why is speaker relevant?
Dr. Aklesh Tandekar's Talks on Assimilate
- 0
Acute respiratory distress syndrome (ARDS), septic shock, thromboembolic disease, hepatic and/or renal dysfunction, central nervous system disease, and worsening of underlying comorbidities are just a few of the serious illnesses that COVID-19 can advance to in both adults and children. In addition, the multisystem inflammatory syndrome in adults (MIS-A), which can cause catastrophic disease, can develop weeks or months following SARS-CoV-2 infection. These Guidelines' initial advice for treating critically unwell people with COVID-19 was largely drawn from knowledge of other causes of sepsis and respiratory failure. 1 However, there is currently a rapidly expanding corpus of research on the management of severely ill COVID-19 patients. In the critical care unit (ICU), treating COVID-19 patients frequently necessitates controlling underlying conditions.
- 0
Acute respiratory distress syndrome (ARDS), septic shock, thromboembolic disease, hepatic and/or renal dysfunction, central nervous system disease, and worsening of underlying comorbidities are just a few of the serious illnesses that COVID-19 can advance to in both adults and children. In addition, the multisystem inflammatory syndrome in adults (MIS-A), which can cause catastrophic disease, can develop weeks or months following SARS-CoV-2 infection. These Guidelines' initial advice for treating critically unwell people with COVID-19 was largely drawn from knowledge of other causes of sepsis and respiratory failure. 1 However, there is currently a rapidly expanding corpus of research on the management of severely ill COVID-19 patients. In the critical care unit (ICU), treating COVID-19 patients frequently necessitates controlling underlying conditions.
- 0
Acute respiratory distress syndrome (ARDS), septic shock, thromboembolic disease, hepatic and/or renal dysfunction, central nervous system disease, and worsening of underlying comorbidities are just a few of the serious illnesses that COVID-19 can advance to in both adults and children. In addition, the multisystem inflammatory syndrome in adults (MIS-A), which can cause catastrophic disease, can develop weeks or months following SARS-CoV-2 infection. These Guidelines' initial advice for treating critically unwell people with COVID-19 was largely drawn from knowledge of other causes of sepsis and respiratory failure. 1 However, there is currently a rapidly expanding corpus of research on the management of severely ill COVID-19 patients. In the critical care unit (ICU), treating COVID-19 patients frequently necessitates controlling underlying conditions.